OTCMKTS:DMTTF Small Pharma (DMTTF) Stock Price, News & Analysis → The Next Step of Their Control Is Here … (From Weiss Ratings) (Ad) Free DMTTF Stock Alerts $0.11 0.00 (0.00%) (As of 10/25/2023) Add Compare Share Share Today's Range$0.11▼$0.1150-Day Range$0.11▼$0.1152-Week Range$0.05▼$0.19VolumeN/AAverage Volume113,204 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisHeadlinesStock AnalysisHeadlines Get Small Pharma alerts: Email Address Ad Weiss RatingsThe Next Step of Their Control Is Here …Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.4 simple steps to protect your privacy and money before it’s too late. About Small Pharma Stock (OTCMKTS:DMTTF)Small Pharma Inc., a biotechnology company, focuses on developing short-duration psychedelic-assisted therapies for the treatment of mental health conditions. Its clinical program is based on N,N, dimethyltryptamine, a naturally occurring psychoactive molecule. The company's product includes SPL026, which is in clinical Phase IIa for the treatment of major depressive disorder; and SPL028, an injectable formulation of deuterated DMT, which is in Phase 1 clinical trial, as well as SPL801B, an oral dosage. Its preclinical stage programs include SPL029, an oral formulation of a tryptamine to treat depressive disorder. The company is headquartered in London, the United Kingdom.Read More DMTTF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart DMTTF Stock News HeadlinesApril 19, 2024 | msn.comWhat drew MIT's investment arm to this small cap pharma company?April 17, 2024 | msn.comMarinus Pharmaceuticals (MRNS) Price Target Decreased by 49.26% to 10.51April 26, 2024 | Weiss Ratings (Ad)The Next Step of Their Control Is Here …Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.April 15, 2024 | msn.comBarclays Initiates Coverage of 4D Molecular Therapeutics (FDMT) with Overweight RecommendationApril 9, 2024 | forbes.comState Of The Pharma Industry: Present And FutureMarch 26, 2024 | markets.businessinsider.comPeeling Back The Layers: Exploring Marinus Pharma Through Analyst InsightsMarch 18, 2024 | msn.comMadrigal Pharmaceuticals First to Receive FDA Clearance for a NASH TreatmentFebruary 15, 2024 | msn.comGland Pharma share price target 2024: 'Core business performance healthy'; time to BUY?April 26, 2024 | Weiss Ratings (Ad)The Next Step of Their Control Is Here …Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.February 8, 2024 | benzinga.comSmall Pharma Inc Stock (OTC:DMTTF) Dividends: History, Yield and DatesJanuary 22, 2024 | marketwatch.com60 Degrees Pharma Plans Tafenoquine Study After FDA MeetingJanuary 9, 2024 | businesswire.comVenatorx Pharmaceuticals and Menarini Group Enter Commercial Agreement for Cefepime-Taniborbactam in 96 CountriesJanuary 4, 2024 | tmcnet.comTerns Pharmaceuticals to Highlight 2024 Priorities and Clinical Milestones at the 42nd Annual J.P. Morgan Healthcare ConferenceJanuary 2, 2024 | msn.comPharma giants are hiking prices on over 500 drugs for 2024, report saysDecember 18, 2023 | msn.comSanten Pharmaceutical Co. - ADR (SNPHY) Price Target Increased by 13.67% to 12.22December 15, 2023 | msn.comPharma’s Frontline: 3 Stocks Driving Revolutionary Drug DevelopmentDecember 13, 2023 | tmcnet.comPharma 4.0 Market is Booming and Expected to Reach $52.41 Billion by 2031 - Explained Details | Updated InsightAce StudyDecember 12, 2023 | insidermonkey.com10 Largest Pharmaceutical Companies in the WorldDecember 6, 2023 | bloomberg.comSanofi Says Pharma Sales Set to Reach €10 Billion by 2030November 28, 2023 | forbes.comBayer, One Of The Oldest Pharmaceutical Companies, Is An Innovation PowerhouseOctober 23, 2023 | benzinga.comCybin Officially Owns Small Pharma: Plans For New 'International Leader' In Psychedelic TherapeuticsOctober 19, 2023 | msn.comSmall Pharma reports Q2 resultsOctober 19, 2023 | finance.yahoo.comSmall Pharma Reports Fiscal Second Quarter 2024 HighlightsOctober 13, 2023 | finanznachrichten.deSmall Pharma Inc.: Small Pharma Announces Voting Results from Annual General and Special Meeting of ShareholdersOctober 4, 2023 | msn.comNewAmsterdam Pharma (NAMS) Price Target Increased by 10.29% to 25.50October 4, 2023 | bizjournals.comChapel Hill pharma avoids Nasdaq delisting with extensionOctober 2, 2023 | markets.businessinsider.comPsyched: DMT & SSRIs For Depression, MDMA Training, Negative Responses To Psychedelics & MoreSee More Headlines Receive DMTTF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Small Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolOTCMKTS:DMTTF CUSIPN/A CIKN/A Webwww.smallpharma.co.uk PhoneN/AFaxN/AEmployees13Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. George TzirasCEO & Non-Independent DirectorMr. David SteelChief Financial OfficerDr. Carol RoutledgeChief Scientific & Medical OfficerMs. Marie Claire Layzell (Age 46)Chief Manufacturing & Devel. Officer & Director Comp: $331.62kDr. Alastair James Riddell M.D. (Age 74)M.Sc., MBChB, MFPM, MRCGP, Ph.D., Chief Operating Officer Ms. Jenny MaguireHead of Brand & CommunicationsMs. Emma HodgeHead of Intellectual PropertyMr. Richard M. Kimel HBA (Age 56)LLB, Corp. Sec. Ms. Sarah HamiltonGroup Financial ControllerMr. Jim RennieDirector of Devel. and Member of Scientific & Advisory BoardMore ExecutivesKey Competitors180 Life SciencesNASDAQ:ATNFW3SBioOTCMKTS:TRSBF60 Degrees PharmaceuticalsNASDAQ:SXTPWAbcamOTCMKTS:ABCZFAdociaOTCMKTS:ADOIFView All Competitors DMTTF Stock Analysis - Frequently Asked Questions How have DMTTF shares performed in 2024? Small Pharma's stock was trading at $0.1117 at the beginning of the year. Since then, DMTTF shares have increased by 0.0% and is now trading at $0.1117. View the best growth stocks for 2024 here. How do I buy shares of Small Pharma? Shares of DMTTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:DMTTF) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe A.I. story nobody is telling you (Read ASAP)TradeSmithForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Small Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
